Artal Group’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-258,687	Closed	-$5.99M	–	133
2023 Q1	$5.99M	Buy	+258,687	New	+$5.99M	0.36%	58
2022 Q1	–	Sell	-180,500	Closed	-$2.94M	–	151
2021 Q4	$2.94M	Hold	180,500	–	–	0.08%	117
2021 Q3	$2.3M	Hold	180,500	–	–	0.05%	126
2021 Q2	$2.55M	Hold	180,500	–	–	0.05%	128
2021 Q1	$2.81M	Hold	180,500	–	–	0.05%	123
2020 Q4	$2.86M	Hold	180,500	–	–	0.06%	110
2020 Q3	$2.19M	Sell	180,500 -9,500	-5%	-$115K	0.05%	108
2020 Q2	$2.2M	Sell	190,000 -10,000	-5%	-$116K	0.06%	106
2020 Q1	$2.74M	Hold	200,000	–	–	0.12%	83
2019 Q4	$1.18M	Hold	200,000	–	–	0.05%	84
2019 Q3	$1.06M	Hold	200,000	–	–	0.04%	87
2019 Q2	$1.54M	Hold	200,000	–	–	0.06%	83
2019 Q1	$3.98M	Hold	200,000	–	–	0.16%	68
2018 Q4	$2.64M	Buy	200,000 +90,000	+82%	+$1.19M	0.1%	63
2018 Q3	$4.04M	Hold	110,000	–	–	0.11%	60
2018 Q2	$3.85M	Hold	110,000	–	–	0.08%	54
2018 Q1	$5.12M	Buy	110,000 +70,000	+175%	+$3.26M	0.06%	44
2017 Q4	$1.5M	Hold	40,000	–	–	0.02%	70
2017 Q3	$2.13M	Buy	40,000 +20,000	+100%	+$1.07M	0.04%	61
2017 Q2	$1.14M	Hold	20,000	–	–	0.02%	74
2017 Q1	$1.08M	Hold	20,000	–	–	0.02%	66
2016 Q4	$1.14M	Hold	20,000	–	–	0.03%	55
2016 Q3	$1.24M	Buy	+20,000	New	+$1.24M	0.02%	63